APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prognostic and Health Management（PHM）

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prognostic and Health Management（PHM） Market Outlook and Growth Opportunities 2026

22 January 2026207 pages

Choose your research edition.

Industry ResearchPrognostic and Health Management（PHM） Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Prognostic and Health Management（PHM） Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prognostic and Health Management（PHM） Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prognostic and Health Management（PHM） Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Prognostic and Health Management（PHM） Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Prognostic and Health Management（PHM） market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prognostic and Health Management（PHM） is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prognostic and Health Management（PHM） is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prognostic and Health Management（PHM） is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prognostic and Health Management（PHM） market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prognostic and Health Management（PHM） market include SKF, Baker Hughes, NSK Global, Emerson, Augury, GE, Meggitt, Uptake and Schaeffler, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Prognostic and Health Management（PHM） market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prognostic and Health Management（PHM） and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prognostic and Health Management（PHM） revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Prognostic and Health Management（PHM） market.

Prognostic and Health Management（PHM） Segment by Company

SKF

Baker Hughes

NSK Global

Emerson

Augury

GE

Meggitt

Uptake

Schaeffler

IBM

Schneider Electric

ABB

Siemens

Ronds Science & Technology

DongHua Testing Technology

Beijing Bohua Xinzhi Technology

Wuhan Zhongyun Kangchong Technology

ChinaEnergy CyberWing Technology

Beijing Weiruida Control System

Prognostic and Health Management（PHM） Segment by Type

On-Premises

Cloud Based

Prognostic and Health Management（PHM） Segment by Application

Petrochemical

Power

Iron and Steel Metallurgy

Cement and Building Materials

Aerospace and Defense

Rail Transit

Intelligent Manufacturing

Others

Prognostic and Health Management（PHM） Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prognostic and Health Management（PHM） status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Prognostic and Health Management（PHM） key companies, revenue, market share, and recent developments.

3. To split the Prognostic and Health Management（PHM） breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Prognostic and Health Management（PHM） market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prognostic and Health Management（PHM） significant trends, drivers, influence factors in global and regions.

6. To analyze Prognostic and Health Management（PHM） competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prognostic and Health Management（PHM） market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prognostic and Health Management（PHM） and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prognostic and Health Management（PHM）.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prognostic and Health Management（PHM） industry.

Chapter 3: Detailed analysis of Prognostic and Health Management（PHM） company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Prognostic and Health Management（PHM） in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Prognostic and Health Management（PHM） in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prognostic and Health Management（PHM） Industry Trends Table 2. Prognostic and Health Management（PHM） Industry Drivers Table 3. Prognostic and Health Management（PHM） Industry Opportunities and Challenges Table 4. Prognostic and Health Management（PHM） Industry Restraints Table 5. Global Prognostic and Health Management（PHM） Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prognostic and Health Management（PHM） Revenue Share by Company (2021-2026) Table 7. Global Prognostic and Health Management（PHM） Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Prognostic and Health Management（PHM） Key Company Manufacturing Base & Headquarters Table 9. Global Prognostic and Health Management（PHM） Company, Product Type & Application Table 10. Global Prognostic and Health Management（PHM） Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Prognostic and Health Management（PHM） by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-Premises Table 15. Significant Companies of Cloud Based Table 16. Global Prognostic and Health Management（PHM） Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Prognostic and Health Management（PHM） Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Prognostic and Health Management（PHM） Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Prognostic and Health Management（PHM） Sales Value Share by Type (2021-2026) Table 20. Global Prognostic and Health Management（PHM） Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Petrochemical Table 22. Significant Companies of Power Table 23. Significant Companies of Iron and Steel Metallurgy Table 24. Significant Companies of Cement and Building Materials Table 25. Significant Companies of Aerospace and Defense Table 26. Significant Companies of Rail Transit Table 27. Significant Companies of Intelligent Manufacturing Table 28. Significant Companies of Others Table 29. Global Prognostic and Health Management（PHM） Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Prognostic and Health Management（PHM） Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Prognostic and Health Management（PHM） Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Prognostic and Health Management（PHM） Sales Value Share by Application (2021-2026) Table 33. Global Prognostic and Health Management（PHM） Sales Value Share by Application (2027-2032) Table 34. Global Prognostic and Health Management（PHM） Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Prognostic and Health Management（PHM） Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Prognostic and Health Management（PHM） Sales Value Share by Region (2021-2026) Table 37. Global Prognostic and Health Management（PHM） Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Prognostic and Health Management（PHM） Sales Value Share by Region (2027-2032) Table 39. Global Prognostic and Health Management（PHM） Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Prognostic and Health Management（PHM） Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Prognostic and Health Management（PHM） Sales Value Market Share by Country (2021-2026) Table 42. Global Prognostic and Health Management（PHM） Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Prognostic and Health Management（PHM） Sales Value Market Share by Country (2027-2032) Table 44. SKF Company Information Table 45. SKF Business Overview Table 46. SKF Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. SKF Prognostic and Health Management（PHM） Product Portfolio Table 48. SKF Recent Development Table 49. Baker Hughes Company Information Table 50. Baker Hughes Business Overview Table 51. Baker Hughes Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Baker Hughes Prognostic and Health Management（PHM） Product Portfolio Table 53. Baker Hughes Recent Development Table 54. NSK Global Company Information Table 55. NSK Global Business Overview Table 56. NSK Global Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. NSK Global Prognostic and Health Management（PHM） Product Portfolio Table 58. NSK Global Recent Development Table 59. Emerson Company Information Table 60. Emerson Business Overview Table 61. Emerson Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Emerson Prognostic and Health Management（PHM） Product Portfolio Table 63. Emerson Recent Development Table 64. Augury Company Information Table 65. Augury Business Overview Table 66. Augury Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Augury Prognostic and Health Management（PHM） Product Portfolio Table 68. Augury Recent Development Table 69. GE Company Information Table 70. GE Business Overview Table 71. GE Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. GE Prognostic and Health Management（PHM） Product Portfolio Table 73. GE Recent Development Table 74. Meggitt Company Information Table 75. Meggitt Business Overview Table 76. Meggitt Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Meggitt Prognostic and Health Management（PHM） Product Portfolio Table 78. Meggitt Recent Development Table 79. Uptake Company Information Table 80. Uptake Business Overview Table 81. Uptake Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Uptake Prognostic and Health Management（PHM） Product Portfolio Table 83. Uptake Recent Development Table 84. Schaeffler Company Information Table 85. Schaeffler Business Overview Table 86. Schaeffler Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Schaeffler Prognostic and Health Management（PHM） Product Portfolio Table 88. Schaeffler Recent Development Table 89. IBM Company Information Table 90. IBM Business Overview Table 91. IBM Prognostic and Health Management（PHM） Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. IBM Prognostic and Health Management（PHM） Product Portfolio Table 93. IBM Recent Development Table 94. Schneider Electric Company Information Table 95. Schneider Electric Business Overview Table 96. Schneider Electric Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Schneider Electric Prognostic and Health Management（PHM） Product Portfolio Table 98. Schneider Electric Recent Development Table 99. ABB Company Information Table 100. ABB Business Overview Table 101. ABB Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. ABB Prognostic and Health Management（PHM） Product Portfolio Table 103. ABB Recent Development Table 104. Siemens Company Information Table 105. Siemens Business Overview Table 106. Siemens Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Siemens Prognostic and Health Management（PHM） Product Portfolio Table 108. Siemens Recent Development Table 109. Ronds Science & Technology Company Information Table 110. Ronds Science & Technology Business Overview Table 111. Ronds Science & Technology Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Ronds Science & Technology Prognostic and Health Management（PHM） Product Portfolio Table 113. Ronds Science & Technology Recent Development Table 114. DongHua Testing Technology Company Information Table 115. DongHua Testing Technology Business Overview Table 116. DongHua Testing Technology Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. DongHua Testing Technology Prognostic and Health Management（PHM） Product Portfolio Table 118. DongHua Testing Technology Recent Development Table 119. Beijing Bohua Xinzhi Technology Company Information Table 120. Beijing Bohua Xinzhi Technology Business Overview Table 121. Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Product Portfolio Table 123. Beijing Bohua Xinzhi Technology Recent Development Table 124. Wuhan Zhongyun Kangchong Technology Company Information Table 125. Wuhan Zhongyun Kangchong Technology Business Overview Table 126. Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Product Portfolio Table 128. Wuhan Zhongyun Kangchong Technology Recent Development Table 129. ChinaEnergy CyberWing Technology Company Information Table 130. ChinaEnergy CyberWing Technology Business Overview Table 131. ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Product Portfolio Table 133. ChinaEnergy CyberWing Technology Recent Development Table 134. Beijing Weiruida Control System Company Information Table 135. Beijing Weiruida Control System Business Overview Table 136. Beijing Weiruida Control System Prognostic and Health Management（PHM） Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Beijing Weiruida Control System Prognostic and Health Management（PHM） Product Portfolio Table 138. Beijing Weiruida Control System Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Prognostic and Health Management（PHM） Product Image Figure 2. Global Prognostic and Health Management（PHM） Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prognostic and Health Management（PHM） Market Size (2021-2032) & (US$ Million) Figure 4. Global Prognostic and Health Management（PHM） Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-Premises Image Figure 8. Cloud Based Image Figure 9. Global Prognostic and Health Management（PHM） Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Prognostic and Health Management（PHM） Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Prognostic and Health Management（PHM） Sales Value Share by Type (2021-2032) Figure 12. Petrochemical Image Figure 13. Power Image Figure 14. Iron and Steel Metallurgy Image Figure 15. Cement and Building Materials Image Figure 16. Aerospace and Defense Image Figure 17. Rail Transit Image Figure 18. Intelligent Manufacturing Image Figure 19. Others Image Figure 20. Global Prognostic and Health Management（PHM） Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Prognostic and Health Management（PHM） Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Prognostic and Health Management（PHM） Sales Value Share by Application (2021-2032) Figure 23. Global Prognostic and Health Management（PHM） Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Prognostic and Health Management（PHM） Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Prognostic and Health Management（PHM） Sales Value (2021-2032) & (US$ Million) Figure 26. North America Prognostic and Health Management（PHM） Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Prognostic and Health Management（PHM） Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Prognostic and Health Management（PHM） Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Prognostic and Health Management（PHM） Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Prognostic and Health Management（PHM） Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Prognostic and Health Management（PHM） Sales Value (2021-2032) & (US$ Million) Figure 32. South America Prognostic and Health Management（PHM） Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Prognostic and Health Management（PHM） Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Prognostic and Health Management（PHM） Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premises
  • Cloud Based
Applications
  • Petrochemical
  • Power
  • Iron and Steel Metallurgy
  • Cement and Building Materials
  • Aerospace and Defense
  • Rail Transit
  • Intelligent Manufacturing
  • Others
Companies covered
  • SKF
  • Baker Hughes
  • NSK Global
  • Emerson
  • Augury
  • GE
  • Meggitt
  • Uptake
  • Schaeffler
  • IBM
  • Schneider Electric
  • ABB
  • Siemens
  • Ronds Science & Technology
  • DongHua Testing Technology
  • Beijing Bohua Xinzhi Technology
  • Wuhan Zhongyun Kangchong Technology
  • ChinaEnergy CyberWing Technology
  • Beijing Weiruida Control System

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prognostic and Health Management（PHM） Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prognostic and Health Management（PHM） Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Prognostic and Health Management（PHM） Market Dynamics
  1. 2.1 Prognostic and Health Management（PHM） Industry Trends
  2. 2.2 Prognostic and Health Management（PHM） Industry Drivers
  3. 2.3 Prognostic and Health Management（PHM） Industry Opportunities and Challenges
  4. 2.4 Prognostic and Health Management（PHM） Industry Restraints
3 Prognostic and Health Management（PHM） Market by Company
  1. 3.1 Global Prognostic and Health Management（PHM） Company Revenue Ranking in 2025
  2. 3.2 Global Prognostic and Health Management（PHM） Revenue by Company (2021-2026)
  3. 3.3 Global Prognostic and Health Management（PHM） Company Ranking (2024-2026)
  4. 3.4 Global Prognostic and Health Management（PHM） Company Manufacturing Base and Headquarters
  5. 3.5 Global Prognostic and Health Management（PHM） Company Product Type and Application
  6. 3.6 Global Prognostic and Health Management（PHM） Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Prognostic and Health Management（PHM） Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Prognostic and Health Management（PHM） Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Prognostic and Health Management（PHM） Market by Type
  1. 4.1 Prognostic and Health Management（PHM） Type Introduction
  2. 4.1.1 On-Premises
  3. 4.1.2 Cloud Based
  4. 4.2 Global Prognostic and Health Management（PHM） Sales Value by Type
  5. 4.2.1 Global Prognostic and Health Management（PHM） Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Prognostic and Health Management（PHM） Sales Value by Type (2021-2032)
  7. 4.2.3 Global Prognostic and Health Management（PHM） Sales Value Share by Type (2021-2032)
5 Prognostic and Health Management（PHM） Market by Application
  1. 5.1 Prognostic and Health Management（PHM） Application Introduction
  2. 5.1.1 Petrochemical
  3. 5.1.2 Power
  4. 5.1.3 Iron and Steel Metallurgy
  5. 5.1.4 Cement and Building Materials
  6. 5.1.5 Aerospace and Defense
  7. 5.1.6 Rail Transit
  8. 5.1.7 Intelligent Manufacturing
  9. 5.1.8 Others
  10. 5.2 Global Prognostic and Health Management（PHM） Sales Value by Application
  11. 5.2.1 Global Prognostic and Health Management（PHM） Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Prognostic and Health Management（PHM） Sales Value by Application (2021-2032)
  13. 5.2.3 Global Prognostic and Health Management（PHM） Sales Value Share by Application (2021-2032)
6 Prognostic and Health Management（PHM） Regional Value Analysis
  1. 6.1 Global Prognostic and Health Management（PHM） Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prognostic and Health Management（PHM） Sales Value by Region (2021-2032)
  3. 6.2.1 Global Prognostic and Health Management（PHM） Sales Value by Region: 2021-2026
  4. 6.2.2 Global Prognostic and Health Management（PHM） Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prognostic and Health Management（PHM） Sales Value (2021-2032)
  7. 6.3.2 North America Prognostic and Health Management（PHM） Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Prognostic and Health Management（PHM） Sales Value (2021-2032)
  10. 6.4.2 Europe Prognostic and Health Management（PHM） Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Prognostic and Health Management（PHM） Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Prognostic and Health Management（PHM） Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Prognostic and Health Management（PHM） Sales Value (2021-2032)
  16. 6.6.2 South America Prognostic and Health Management（PHM） Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Prognostic and Health Management（PHM） Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Prognostic and Health Management（PHM） Sales Value Share by Country, 2025 VS 2032
7 Prognostic and Health Management（PHM） Country-level Value Analysis
  1. 7.1 Global Prognostic and Health Management（PHM） Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prognostic and Health Management（PHM） Sales Value by Country (2021-2032)
  3. 7.2.1 Global Prognostic and Health Management（PHM） Sales Value by Country (2021-2026)
  4. 7.2.2 Global Prognostic and Health Management（PHM） Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Prognostic and Health Management（PHM） Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Prognostic and Health Management（PHM） Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Prognostic and Health Management（PHM） Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SKF
  2. 8.1.1 SKF Company Information
  3. 8.1.2 SKF Business Overview
  4. 8.1.3 SKF Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SKF Prognostic and Health Management（PHM） Product Portfolio
  6. 8.1.5 SKF Recent Developments
  7. 8.2 Baker Hughes
  8. 8.2.1 Baker Hughes Company Information
  9. 8.2.2 Baker Hughes Business Overview
  10. 8.2.3 Baker Hughes Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baker Hughes Prognostic and Health Management（PHM） Product Portfolio
  12. 8.2.5 Baker Hughes Recent Developments
  13. 8.3 NSK Global
  14. 8.3.1 NSK Global Company Information
  15. 8.3.2 NSK Global Business Overview
  16. 8.3.3 NSK Global Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NSK Global Prognostic and Health Management（PHM） Product Portfolio
  18. 8.3.5 NSK Global Recent Developments
  19. 8.4 Emerson
  20. 8.4.1 Emerson Company Information
  21. 8.4.2 Emerson Business Overview
  22. 8.4.3 Emerson Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Emerson Prognostic and Health Management（PHM） Product Portfolio
  24. 8.4.5 Emerson Recent Developments
  25. 8.5 Augury
  26. 8.5.1 Augury Company Information
  27. 8.5.2 Augury Business Overview
  28. 8.5.3 Augury Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Augury Prognostic and Health Management（PHM） Product Portfolio
  30. 8.5.5 Augury Recent Developments
  31. 8.6 GE
  32. 8.6.1 GE Company Information
  33. 8.6.2 GE Business Overview
  34. 8.6.3 GE Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GE Prognostic and Health Management（PHM） Product Portfolio
  36. 8.6.5 GE Recent Developments
  37. 8.7 Meggitt
  38. 8.7.1 Meggitt Company Information
  39. 8.7.2 Meggitt Business Overview
  40. 8.7.3 Meggitt Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Meggitt Prognostic and Health Management（PHM） Product Portfolio
  42. 8.7.5 Meggitt Recent Developments
  43. 8.8 Uptake
  44. 8.8.1 Uptake Company Information
  45. 8.8.2 Uptake Business Overview
  46. 8.8.3 Uptake Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Uptake Prognostic and Health Management（PHM） Product Portfolio
  48. 8.8.5 Uptake Recent Developments
  49. 8.9 Schaeffler
  50. 8.9.1 Schaeffler Company Information
  51. 8.9.2 Schaeffler Business Overview
  52. 8.9.3 Schaeffler Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Schaeffler Prognostic and Health Management（PHM） Product Portfolio
  54. 8.9.5 Schaeffler Recent Developments
  55. 8.10 IBM
  56. 8.10.1 IBM Company Information
  57. 8.10.2 IBM Business Overview
  58. 8.10.3 IBM Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IBM Prognostic and Health Management（PHM） Product Portfolio
  60. 8.10.5 IBM Recent Developments
  61. 8.11 Schneider Electric
  62. 8.11.1 Schneider Electric Company Information
  63. 8.11.2 Schneider Electric Business Overview
  64. 8.11.3 Schneider Electric Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Schneider Electric Prognostic and Health Management（PHM） Product Portfolio
  66. 8.11.5 Schneider Electric Recent Developments
  67. 8.12 ABB
  68. 8.12.1 ABB Company Information
  69. 8.12.2 ABB Business Overview
  70. 8.12.3 ABB Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ABB Prognostic and Health Management（PHM） Product Portfolio
  72. 8.12.5 ABB Recent Developments
  73. 8.13 Siemens
  74. 8.13.1 Siemens Company Information
  75. 8.13.2 Siemens Business Overview
  76. 8.13.3 Siemens Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Siemens Prognostic and Health Management（PHM） Product Portfolio
  78. 8.13.5 Siemens Recent Developments
  79. 8.14 Ronds Science & Technology
  80. 8.14.1 Ronds Science & Technology Company Information
  81. 8.14.2 Ronds Science & Technology Business Overview
  82. 8.14.3 Ronds Science & Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ronds Science & Technology Prognostic and Health Management（PHM） Product Portfolio
  84. 8.14.5 Ronds Science & Technology Recent Developments
  85. 8.15 DongHua Testing Technology
  86. 8.15.1 DongHua Testing Technology Company Information
  87. 8.15.2 DongHua Testing Technology Business Overview
  88. 8.15.3 DongHua Testing Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  89. 8.15.4 DongHua Testing Technology Prognostic and Health Management（PHM） Product Portfolio
  90. 8.15.5 DongHua Testing Technology Recent Developments
  91. 8.16 Beijing Bohua Xinzhi Technology
  92. 8.16.1 Beijing Bohua Xinzhi Technology Company Information
  93. 8.16.2 Beijing Bohua Xinzhi Technology Business Overview
  94. 8.16.3 Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Beijing Bohua Xinzhi Technology Prognostic and Health Management（PHM） Product Portfolio
  96. 8.16.5 Beijing Bohua Xinzhi Technology Recent Developments
  97. 8.17 Wuhan Zhongyun Kangchong Technology
  98. 8.17.1 Wuhan Zhongyun Kangchong Technology Company Information
  99. 8.17.2 Wuhan Zhongyun Kangchong Technology Business Overview
  100. 8.17.3 Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Wuhan Zhongyun Kangchong Technology Prognostic and Health Management（PHM） Product Portfolio
  102. 8.17.5 Wuhan Zhongyun Kangchong Technology Recent Developments
  103. 8.18 ChinaEnergy CyberWing Technology
  104. 8.18.1 ChinaEnergy CyberWing Technology Company Information
  105. 8.18.2 ChinaEnergy CyberWing Technology Business Overview
  106. 8.18.3 ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ChinaEnergy CyberWing Technology Prognostic and Health Management（PHM） Product Portfolio
  108. 8.18.5 ChinaEnergy CyberWing Technology Recent Developments
  109. 8.19 Beijing Weiruida Control System
  110. 8.19.1 Beijing Weiruida Control System Company Information
  111. 8.19.2 Beijing Weiruida Control System Business Overview
  112. 8.19.3 Beijing Weiruida Control System Prognostic and Health Management（PHM） Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Beijing Weiruida Control System Prognostic and Health Management（PHM） Product Portfolio
  114. 8.19.5 Beijing Weiruida Control System Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst